Want to see MDLN full AI Analyst Report?
Total Valuation
Medline has a market cap or net worth of $45.04B. The enterprise value is $50.93K.
Market Cap$45.04B
Enterprise Value$50.93K
Share Statistics
Medline has 877,351,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding877,351,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medline’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.69%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.69%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee631.82K
Profits Per Employee25.76K
Employee Count45,000
Asset Turnover0.74
Inventory Turnover4.39
Valuation Ratios
The current PE Ratio of Medline is 39.8. Medline’s PEG ratio is -4.96.
PE Ratio39.8
PS Ratio1.20
PB Ratio3.18
Price to Fair Value3.18
Price to FCF26.29
Price to Operating Cash Flow14.74
PEG Ratio-4.96
Income Statement
In the last 12 months, Medline had revenue of 28.43B and earned 1.16B in profits. Earnings per share was 1.43.
Revenue28.43B
Gross Profit7.52B
Operating Income2.21B
Pretax Income1.25B
Net Income1.16B
EBITDA1.95B
Earnings Per Share (EPS)1.43
Cash Flow
In the last 12 months, operating cash flow was 1.99B and capital expenditures 34.00M, giving a free cash flow of 2.03B billion.
Operating Cash Flow1.99B
Free Cash Flow2.03B
Free Cash Flow per Share2.31
Dividends & Yields
Medline pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.78
52-Week Price Change-16.44%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)7.73M
Important Dates
Medline upcoming earnings date is Nov 10, 2026, Before Open (Confirmed).
Last Earnings DateAug 5, 2026
Next Earnings DateNov 10, 2026
Ex-Dividend Date―
Financial Position
Medline as a current ratio of 4.29, with Debt / Equity ratio of 109.23%
Current Ratio4.29
Quick Ratio2.37
Debt to Market Cap0.37
Net Debt to EBITDA5.44
Interest Coverage Ratio2.72
Taxes
In the past 12 months, Medline has paid 91.00M in taxes.
Income Tax91.00M
Effective Tax Rate0.07
Enterprise Valuation
Medline EV to EBITDA ratio is 22.91, with an EV/FCF ratio of 34.48.
EV to Sales1.57
EV to EBITDA22.91
EV to Free Cash Flow34.48
EV to Operating Cash Flow25.65
Balance Sheet
Medline has $2.68B in cash and marketable securities with $12.64B in debt, giving a net cash position of -$9.96B billion.
Cash & Marketable Securities$2.68B
Total Debt$12.64B
Net Cash-$9.96B
Net Cash Per Share-$11.36
Tangible Book Value Per Share-$3.31
Margins
Gross margin is 25.02%, with operating margin of 7.78%, and net profit margin of 4.08%.
Gross Margin25.02%
Operating Margin7.78%
Pretax Margin4.39%
Net Profit Margin4.08%
EBITDA Margin6.87%
EBIT Margin4.39%
Analyst Forecast
The average price target for Medline is $45.89, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$45.89
Price Target Upside33.94% Upside
Analyst ConsensusStrong Buy
Analyst Count20
Revenue Growth Forecast12.12%
EPS Growth Forecast-46.11%